TransEnterix (NYSE:TRXC) said today that it agreed to deal its SurgiBot assets to Chinese medtech investment firm Great Belief International for $29 million.
The agreement calls for Research Triangle Park, N.C.-based TransEnterix to retain the distribution rights to SurgiBot, which it shelved last year, outside of the U.S.
